Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention

A. T. Podany, J. Leon-Cruz, J. Hakim, K. Supparatpinyo, A. Omoz-Oarhe, D. Langat, N. Mwelase, C. Kanyama, A. Gupta, C. A. Benson, R. E. Chaisson, S. Swindells, C. V. Fletcher, Peter Kim, Daniel Johnson, Laura Moran, Janet Andersen, Yajing Bao, Shirley Wu, Christina Blanchard-HoranAnn Walawander, Katherine Shin, Ruth Ebiasah, David Holland, Marc Antoine Jeanjuste, Eric Nuermberger, Sandy Pillay, Ian Sanne, Janet Nicotera, David Shugarts, Amina Shali, Jimi Tutko, Brigitte Demers, Marilyn Maroni, Jorge L. Sanchez, David Iglesias, Javier Lama, Mitch Matoga, Guilherme Do Amaral Calvet, Ronald Kibet Tonui, Taolo Modise, Margaret Kasaro, Kogieleum Naidoo, Deelip Kadam, William Burman

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention'. Together they form a unique fingerprint.

Medicine & Life Sciences